How Innovators Are Addressing GLP-1s, Obesity and MSK
Leaders from Blue Cross and Blue Shield of Illinois, Independent Health, Evry Health and Vori Health
discuss GP-1s and their role in addressing the global challenge of obesity. The panel shares innovative, multidisciplinary strategies you can implement to complement lifestyle interventions and other therapeutic approaches in your organization.
* Improving outcomes by pairing GLP-1s with evidence-based behavior change
* Considering musculoskeletal (MSK) health in obesity treatment
* Understanding the role of GLP-1s in delivering value-based care
Shelley Turk, Divisional Senior Vice President of Health Care Delivery, Blue Cross and Blue Shield of Illinois
Martin Burruano, Vice President, Pharmacy Services, Independent Health
Mamata Majmundar, MD, Chief Medical Officer, Evry Health
Mary O’Connor, MD, FAAOS, Co-Founder & Chief Medical Officer, Vori Health
This episode is sponsored by Vori Health
Vori Health is a specialty medical practice delivering a virtual-first musculoskeletal (MSK) solution to help members get back to their lives faster. As the only nationwide MSK practice with doctor-led care teams, Vori Health is the most convenient way to access appropriate care for back, neck, and joint pain without bouncing around the healthcare system. Whether members need a diagnosis, non-opioid prescription, personalized physical therapy, or health coaching, they can turn to Vori Health for evidence-based care and effective end-to-end support. This holistic model reduces unnecessary surgeries, enables faster recoveries, and lowers MSK spend with up to a 4:1 ROI. For more information visit www.vorihealth.com.